GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed. The consequences of advanced chronic ...

Kidney Health New Zealand says a simple, $12 test could prevent hundreds of people languishing on waitlists for a kidney ...